Literature DB >> 8099651

Torsades de pointes and proarrhythmia.

J Ben-David1, D P Zipes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8099651     DOI： 10.1016/0140-6736(93)90708-o

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 2.  Choosing the right beta-blocker. A guide to selection.

Authors:  J R Hampton
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

Review 3.  Therapeutic controversies in the management of acute anaphylaxis.

Authors:  A F Brown
Journal:  J Accid Emerg Med       Date:  1998-03

Review 4.  Proarrhythmia, a serious complication of antiarrhythmic drugs.

Authors:  P J Podrid
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

5.  Characteristics of idiopathic ventricular tachycardia originating above the pulmonary valve.

Authors:  Hisashi Yokoshiki; Kazuya Mizukami; Hirofumi Mitsuyama; Masaya Watanabe; Taro Tenma; Hiroyuki Tsutsui
Journal:  Heart Vessels       Date:  2015-03-03       Impact factor: 2.037

6.  Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes.

Authors:  S J Coker; A J Batey; I D Lightbown; M E Díaz; D A Eisner
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

7.  Effectiveness of ibutilide in cardioversion of persistent atrial fibrillation in patients with dual chamber stimulation.

Authors:  Massimo Santini; Carlo Pignalberi; Renato Ricci; Leonardo Calò; Luca Santini
Journal:  J Interv Card Electrophysiol       Date:  2003-08       Impact factor: 1.900

8.  Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort.

Authors:  Abigail L Coughtrie; Elijah R Behr; Deborah Layton; Vanessa Marshall; A John Camm; Saad A W Shakir
Journal:  BMJ Open       Date:  2017-10-16       Impact factor: 2.692

9.  Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage.

Authors:  Shinji Fukui; Hiroshi Katoh; Nobusuke Tsuzuki; Shoichiro Ishihara; Naoki Otani; Hidetoshi Ooigawa; Terushige Toyooka; Akira Ohnuki; Takahito Miyazawa; Hiroshi Nawashiro; Katsuji Shima
Journal:  Crit Care       Date:  2003-02-21       Impact factor: 9.097

10.  Risk of cardiac events with azithromycin-A prediction model.

Authors:  Haridarshan Patel; Robert J DiDomenico; Katie J Suda; Glen T Schumock; Gregory S Calip; Todd A Lee
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.